MarketInOut Stock Screener Log In | Sign Up

Phapros

ISE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:43
Phapros stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeISE
Market Capitalization233,520 mln
Float282 mln

EPS

48.00
Exceptional

P / E

5.62
Undervalued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-3.06
Reliable

Relative Strength

68 / 100
Outperforming

Debt / Equity

1.67
High leverage

Business Description

PT Phapros Tbk is an Indonesian pharmaceutical company founded in 1954 and based in South Jakarta, operating as part of the larger Kimia Farma group. It produces a wide range of medicines sold both with and without a prescription, along with medical devices and contract manufacturing services for other companies. Some of its well-known consumer products include Antimo, Livron B Plex, and Noza, which are available directly to the public. The company also sells its products internationally through export.

Key Fundamentals

EPS48.00
P/E5.62
ROE10.09
RPS1,149
ROIC5.17
ROA2.85
Interest Cover1.93
EBITDA, mln154,935
EV / EBITDA5.15
EV / EBIT7.63
Revenue, mln965,501
EV / Revenue0.83

Quote Details

Last 270.00
Change 2 (0.75%)
Open 270.00
Volume 69,500
Turnover 18,765,000
Average Volume 293,719

Financial Ratios

Pre-Tax Profit Margin6
Leverage Ratio3.41
Current Ratio2.05
Price / Book0.54
Price / Tangible Book0.63
Price / Cash Flow1.47
Price / Free Cash Flow1.65
Debt / Equity1.67
Price / Sales0.25

Financial Strength

Altman Z-Score1
Piotroski F-Score 8 / 9
Beneish M-Score-3.06
Price to Intrinsic Value0.20
Price to Graham Number0.43
Shiller PE Ratio1.64

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.75% 64 / 100   
1 Month -4.93% 69 / 100   
2 Months 3.85% 75 / 100   
6 Months -6.43% 72 / 100   
1 Year -15.62% 51 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog